Tag: $Roche Holding AG’s

Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche

Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug candidate.

Roche to halt lung-cancer drug trial after disappointing data

Roche Holding said it plans to halt a mid- and late-stage clinical study for a combination of drugs to treat lung cancer after it failed to meet the trial’s primary efficacy goals.

Roche Strikes $3.1 Billion Deal for Obesity Drugmaker. It’s Hoping to Compete with Eli Lilly, Novo Nordisk.

Roche has agreed to buy obesity-drug developer Carmot Therapeutics for up to $3.1 billion.

Swiss pharma giant Roche agrees $7.1 billion deal to buy Telavant Holdings

Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction.

Roche’s cancer therapy gets US FDA nod, heating up competition with AbbVie

The U.S. Food and Drug Administration (FDA) greenlighted Roche Holding AG’s experimental therapy to treat a type of advanced blood cancer, nearly a month after the approval of a rival therapy from AbbVie Inc.